Cargando…

Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review

Lymphatic filariasis (LF) is targeted for elimination by the year 2020. The Global Programme for Elimination of LF (GPELF) aims to achieve elimination by interrupting transmission through annual mass drug administration (MDA) of albendazole with ivermectin or diethylcarbamazine. The program has succ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srividya, Adinarayanan, Subramanian, Swaminathan, Jambulingam, Purushothaman, Vijayakumar, Balakrishnan, Dinesh Raja, Jeyapal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554002/ https://www.ncbi.nlm.nih.gov/pubmed/31239804 http://dx.doi.org/10.2147/RRTM.S134186

Ejemplares similares

Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation
por: Swaminathan, Subramanian, et al.
Publicado: (2012)

Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India
por: Subramanian, Swaminathan, et al.
Publicado: (2020)

Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India
por: Subramanian, Swaminathan, et al.
Publicado: (2017)

Probable sociobehavioural and environmental risk factors for dengue transmission in Puducherry, India – An exploratory study
por: Jeyapal, Dinesh Raja, et al.
Publicado: (2022)

Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India
por: Dinesh, Raja Jeyapal, et al.
Publicado: (2023)

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
por: Jambulingam, Purushothaman, et al.
Publicado: (2016)

Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India – a cross sectional study
por: Dinesh, Raja Jeyapal, et al.
Publicado: (2023)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
por: Jambulingam, Purushothaman, et al.
Publicado: (2021)

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India
por: Sabesan, S., et al.
Publicado: (2022)

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach
por: Goss, Charles W., et al.
Publicado: (2019)

Delimitation of lymphatic filariasis transmission risk areas: a geo-environmental approach
por: Sabesan, Shanmugavelu, et al.
Publicado: (2006)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
por: Weil, Gary J., et al.
Publicado: (2019)

Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework
por: Smith, Morgan E., et al.
Publicado: (2017)

Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis
por: Jambulingam, Purushothaman, et al.
Publicado: (2022)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Defining the cost of the Egyptian lymphatic filariasis elimination programme
por: Ramzy, Reda MR, et al.
Publicado: (2005)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Population Migration: Implications for Lymphatic Filariasis Elimination Programmes
por: Ramaiah, K. D.
Publicado: (2013)

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone
por: Bah, Yakuba M., et al.
Publicado: (2020)

Progress towards elimination of lymphatic filariasis in the Americas region
por: Fontes, Gilberto, et al.
Publicado: (2020)

Caring for patients in the global programme to eliminate lymphatic filariasis
por: Mackenzie, Charles D, et al.
Publicado: (2020)

Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models
por: Stolk, Wilma A, et al.
Publicado: (2018)

Haiti National Program for the Elimination of Lymphatic Filariasis—A Model of Success in the Face of Adversity
por: Oscar, Roland, et al.
Publicado: (2014)

Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects
por: Swaminathan, Subramanian, et al.
Publicado: (2008)

Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China
por: Fang, Yuan, et al.
Publicado: (2019)

Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience
por: Nandha, B, et al.
Publicado: (2007)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Global Elimination of Lymphatic Filariasis: Addressing the Public Health Problem
por: Addiss, David G.
Publicado: (2010)

Global Elimination of Lymphatic Filariasis: A “Mass Uprising of Compassion”
por: Addiss, David G.
Publicado: (2013)

Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti
por: Lammie, Patrick J., et al.
Publicado: (2017)

Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8lebkftmi2j374u8a19k3fsi99